Skip to content

Malingering in ADHD and the use of symptom validity tests in neuropsychological assessment.

Malingering in ADHD and the use of symptom validity tests in neuropsychological assessment. - The effects of suboptimal effort on neuropsychological assessment by ADHD.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32942
Enrollment
200
Registered
2009-09-05
Start date
2009-10-23
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malingering Malingering suboptimal effort

Interventions

- SCL-90
questionnaire for psychiatric complaints. - BDI
questionnaire for major depression. - Pictorial Representation of Illness and Self Measure -Rev. 2
test that measures suffering. - Continuous Performance Test
Computer test that measures reaction time and inhibition. - Stroop Test
Test that measures attention and distraction. - Amsterdamse Korte Termijn Geheugen Test (AKTG)
Test that measures symptom validity. - Word Memory Test
Computer test that measures memory and also has an index for suboptimal effort. - Structured Inventory for Malingered Symptoms
Questionnaire of symptom validity. - Wender Utah Rating Scale
Questionnaire for diagnosis of ADHD en ADD. - Strategy questionnaire
Questionnaire that asks for applied strategy of malingering.

Sponsors

GGZ regio Breda (Breda)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 18-50 - Classified with ADHD according DSM IV - No objection to pass one dosage of methylfenidate - Permission of responsible medicist to skip one dosage of methylfenidate

Exclusion criteria

Exclusion criteria: - Not Dutch-speaking - Usage of psychotrope medication or neuroleptica - Comorbidity wit Psychotic Disorders or Bipolar Disorder. Exclusion criteria confirmed by responsible medicist. - Comorbidity with major depression. Excluded by administration of a depression questionnaire.

Design outcomes

Primary

MeasureTime frame
Sensitivity en specificity of symptom validity tests for clinical use by patients with ADHD.

Secondary

MeasureTime frame
Malingerparameters on regular neuropsychological tests

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)